» Articles » PMID: 36773784

The Parkinson-Associated Toxin Paraquat Shifts Physiological α-Synuclein Tetramers Toward Monomers That Can Be Calpain-Truncated and Form Oligomers

Overview
Journal Am J Pathol
Publisher Elsevier
Specialty Pathology
Date 2023 Feb 11
PMID 36773784
Authors
Affiliations
Soon will be listed here.
Abstract

Abnormal aggregation of α-synuclein (αS) is thought to initiate neuronal dysfunction and death in Parkinson disease (PD). In addition to higher-molecular-weight, oligomeric, and polymeric forms of αS associated with neurotoxicity and disease, recent findings indicate the occurrence of physiological tetrameric assemblies in healthy neurons in culture and in brain. Herein, the PD-associated neurotoxin paraquat reduced physiological tetramers and led to calpain-truncated monomers and an approximately 70-kDa apparent oligomer different in size from physiological αS multimers. These truncated and oligomeric forms could also be generated by calpain cleavage of pure, recombinant human αS in vitro. Moreover, they were detected in the brains of tetramer-abrogating, E46K-amplified (3K) mice that model PD. These results indicate that paraquat triggers membrane damage and aberrant calpain activity that can induce a pathologic shift of tetramers toward an excess of full-length and truncated monomers, the accumulation of αS oligomers, and insoluble cytoplasmic αS puncta. The findings suggest that an environmental precipitant of PD can alter αS tetramer/monomer equilibrium, as already shown for several genetically caused forms of PD.

Citing Articles

Parkinson disease-associated toxic exposures selectively up-regulate vesicular glutamate transporter vGlut2 in a model of human cortical neurons.

Clark K, White A, Paslawski W, Alexander K, Peng S, Young-Pearse T Mol Biol Cell. 2025; 36(2):br4.

PMID: 39745872 PMC: 11809304. DOI: 10.1091/mbc.E24-08-0376.


Research Priorities on the Role of α-Synuclein in Parkinson's Disease Pathogenesis.

Burre J, Edwards R, Halliday G, Lang A, Lashuel H, Melki R Mov Disord. 2024; 39(10):1663-1678.

PMID: 38946200 PMC: 11808831. DOI: 10.1002/mds.29897.


Aggregation-resistant alpha-synuclein tetramers are reduced in the blood of Parkinson's patients.

De Boni L, Wallis A, Watson A, Ruiz-Riquelme A, Leyland L, Bourinaris T EMBO Mol Med. 2024; 16(7):1657-1674.

PMID: 38839930 PMC: 11250827. DOI: 10.1038/s44321-024-00083-5.


Generation of G51D and 3D mice reveals decreased α-synuclein tetramer-monomer ratios promote Parkinson's disease phenotypes.

Nuber S, Zhang X, McCaffery T, Moors T, Adom M, Hahn W NPJ Parkinsons Dis. 2024; 10(1):47.

PMID: 38424059 PMC: 10904737. DOI: 10.1038/s41531-024-00662-w.


LRP10 and α-synuclein transmission in Lewy body diseases.

Carreras Mascaro A, Grochowska M, Boumeester V, Dits N, Bilgi E, Breedveld G Cell Mol Life Sci. 2024; 81(1):75.

PMID: 38315424 PMC: 10844361. DOI: 10.1007/s00018-024-05135-0.


References
1.
Dettmer U, Ramalingam N, von Saucken V, Kim T, Newman A, Terry-Kantor E . Loss of native α-synuclein multimerization by strategically mutating its amphipathic helix causes abnormal vesicle interactions in neuronal cells. Hum Mol Genet. 2017; 26(18):3466-3481. PMC: 5884392. DOI: 10.1093/hmg/ddx227. View

2.
Liu C, Giasson B, Lewis K, Lee V, DeMartino G, Thomas P . A precipitating role for truncated alpha-synuclein and the proteasome in alpha-synuclein aggregation: implications for pathogenesis of Parkinson disease. J Biol Chem. 2005; 280(24):22670-8. DOI: 10.1074/jbc.M501508200. View

3.
Westphal C, Chandra S . Monomeric synucleins generate membrane curvature. J Biol Chem. 2012; 288(3):1829-40. PMC: 3548493. DOI: 10.1074/jbc.M112.418871. View

4.
Martines A, Stifanese R, Faelli E, Perasso L, Melloni I, Ruggeri P . Calpain-1 resident in lipid raft/caveolin-1 membrane microdomains plays a protective role in endothelial cells. Biochimie. 2016; 133:20-27. DOI: 10.1016/j.biochi.2016.12.002. View

5.
Emmer K, Waxman E, Covy J, Giasson B . E46K human alpha-synuclein transgenic mice develop Lewy-like and tau pathology associated with age-dependent, detrimental motor impairment. J Biol Chem. 2011; 286(40):35104-18. PMC: 3186371. DOI: 10.1074/jbc.M111.247965. View